|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1401 to 1500 out of 2785 for Tgfb1

0.02s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
GXD Expression
Probe: MGI:5774565
Assay Type: RNA in situ
Annotation Date: 2016-06-01
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1791024
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:5774641
Age: embryonic day 16.5
Image: 6A
Note: High levels of expression in ossifying tissues of the upper and lower jaw.
Specimen Label: 6A
Detected: true
Specimen Num: 9
GXD Expression  
Probe: MGI:3838830
Assay Type: Immunohistochemistry
Annotation Date: 2009-04-07
Strength: Present
Sex: Not Specified
Emaps: EMAPS:2672025
Pattern: Not Specified
Stage: TS25
Assay Id: MGI:3838959
Age: embryonic day 17.5
Image: 11E
Specimen Label: 11E
Detected: true
Specimen Num: 42
GXD Expression  
Probe: MGI:3055307
Assay Type: RNA in situ
Annotation Date: 2013-02-21
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:2672025
Stage: TS25
Assay Id: MGI:5465429
Age: embryonic day 17.5
Image: 10
Note: Little of no expression is seen in the follicle proper.
Specimen Label: 10
Detected: false
Specimen Num: 2
GXD Expression  
Probe: MGI:5544243
Assay Type: Immunohistochemistry
Annotation Date: 2014-02-16
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3274819
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:5544248
Age: embryonic day 11.5
Image: E11.5
Specimen Label: E11.5
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:5544243
Assay Type: Immunohistochemistry
Annotation Date: 2014-02-16
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3274820
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:5544248
Age: embryonic day 12.5
Image: E12.5
Specimen Label: E12.5
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:3838830
Assay Type: Immunohistochemistry
Annotation Date: 2009-04-07
Strength: Present
Sex: Not Specified
Emaps: EMAPS:2778221
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:3838959
Age: embryonic day 13.5
Note: Expression in the cuboidal epithelial lining of the metanephric tubules, but not in the basement membranes.
Specimen Label: E13.5 metanephros
Detected: true
Specimen Num: 21
GXD Expression  
Probe: MGI:3838830
Assay Type: Immunohistochemistry
Annotation Date: 2009-04-07
Strength: Present
Sex: Not Specified
Emaps: EMAPS:2778222
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:3838959
Age: embryonic day 14.5
Note: Expression in the cuboidal epithelial lining of the metanephric tubules, but not in the basement membranes.
Specimen Label: E14.5 metanephros
Detected: true
Specimen Num: 22
GXD Expression  
Probe: MGI:3838830
Assay Type: Immunohistochemistry
Annotation Date: 2009-04-07
Strength: Present
Sex: Not Specified
Emaps: EMAPS:2778223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:3838959
Age: embryonic day 15.5
Note: Expression in the tubule epithelium.
Specimen Label: E15.5 metanephros
Detected: true
Specimen Num: 23
GXD Expression  
Probe: MGI:3838830
Assay Type: Immunohistochemistry
Annotation Date: 2009-04-07
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:2778225
Pattern: Regionally restricted
Stage: TS25
Assay Id: MGI:3838959
Age: embryonic day 17.5
Note: Decreased expression in the tubular epithelium.
Specimen Label: E17.5 metanephros
Detected: true
Specimen Num: 24
GXD Expression
Probe: MGI:3839388
Assay Type: Immunohistochemistry
Annotation Date: 2016-05-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1881223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:5771676
Age: embryonic day 15.0
Image: 4B
Note: Expression is in the connective tissue surrounding the glandular epithelium.
Specimen Label: 4B
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:5529501
Assay Type: RNA in situ
Annotation Date: 2014-01-21
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1786921
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:5529504
Age: embryonic day 13.5
Image: 4B
Note: Expression is in the endocardium.
Specimen Label: 4B
Detected: true
Specimen Num: 13
GXD Expression
Probe: MGI:5529501
Assay Type: RNA in situ
Annotation Date: 2014-01-21
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1786921
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:5529504
Age: embryonic day 13.5
Image: 4F
Note: Expression is in the endocardium.
Specimen Label: 4F
Detected: true
Specimen Num: 14
GXD Expression
Probe: MGI:5529501
Assay Type: RNA in situ
Annotation Date: 2014-01-21
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1786921
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:5529504
Age: embryonic day 13.5
Image: 4J
Note: Expression is in the endocardium.
Specimen Label: 4J
Detected: true
Specimen Num: 15
GXD Expression
Probe: MGI:5529501
Assay Type: RNA in situ
Annotation Date: 2014-01-21
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1786922
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:5529504
Age: embryonic day 14.5
Image: 5B
Note: Expression is in the endocardium.
Specimen Label: 5B
Detected: true
Specimen Num: 16
GXD Expression
Probe: MGI:5529501
Assay Type: RNA in situ
Annotation Date: 2014-01-21
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1786922
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:5529504
Age: embryonic day 14.5
Image: 5F
Note: Expression is in the endocardium.
Specimen Label: 5F
Detected: true
Specimen Num: 17
GXD Expression
Probe: MGI:5529501
Assay Type: RNA in situ
Annotation Date: 2014-01-21
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1786923
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:5529504
Age: embryonic day 15.5
Image: 6B
Note: Expression is in the endocardium.
Specimen Label: 6B
Detected: true
Specimen Num: 18
GXD Expression
Probe: MGI:5529501
Assay Type: RNA in situ
Annotation Date: 2014-01-21
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1786923
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:5529504
Age: embryonic day 15.5
Image: 6F
Note: Expression is in the endocardium.
Specimen Label: 6F
Detected: true
Specimen Num: 19
GXD Expression
Probe: MGI:5529501
Assay Type: RNA in situ
Annotation Date: 2014-01-21
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1786923
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:5529504
Age: embryonic day 15.5
Image: 6J
Note: Expression is in the endocardium.
Specimen Label: 6J
Detected: true
Specimen Num: 20
GXD Expression  
Probe: MGI:3839388
Assay Type: Immunohistochemistry
Annotation Date: 2016-07-05
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1657717
Stage: TS17
Assay Id: MGI:5779848
Age: embryonic day 10.5
Image: 3D
Note: No expression in epithelial tissues, including the central nervous system, mesonephric ducts, hindgut and epidermis.
Specimen Label: 3D
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3674122
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:6120497
Age: embryonic day 14.5
Specimen Label: 1B
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3674021
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:6120497
Age: embryonic day 13.5
Specimen Label: 1A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3674224
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:6120497
Age: embryonic day 16.5
Specimen Label: 1C
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808224
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6120497
Age: embryonic day 16.5
Specimen Label: 1C
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808227
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:6120497
Age: postnatal day 0.5
Specimen Label: 1F
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808227
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:6120497
Age: postnatal day 3.5
Specimen Label: 1H
Detected: true
Specimen Num: 8
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808622
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:6120497
Age: embryonic day 14.5
Specimen Label: 1B
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808624
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6120497
Age: embryonic day 16.5
Specimen Label: 1C
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808627
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:6120497
Age: postnatal day 0.5
Specimen Label: 1E
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808627
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:6120497
Age: postnatal day 3.5
Specimen Label: 1H
Detected: true
Specimen Num: 8
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808522
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:6120497
Age: embryonic day 14.5
Specimen Label: 1B
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808524
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6120497
Age: embryonic day 16.5
Specimen Label: 1C
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:3839388
Assay Type: Immunohistochemistry
Annotation Date: 2016-05-25
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808123
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5771676
Age: embryonic day 15.0
Image: 11B
Specimen Label: 11B
Detected: true
Specimen Num: 25
GXD Expression  
Probe: MGI:3839388
Assay Type: Immunohistochemistry
Annotation Date: 2016-05-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3808123
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5771676
Age: embryonic day 15.0
Image: 5A
Specimen Label: 5A
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3808122
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:6120497
Age: embryonic day 14.5
Specimen Label: 1B
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808124
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6120497
Age: embryonic day 16.5
Specimen Label: 1C
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3808127
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:6120497
Age: postnatal day 0.5
Specimen Label: 1E
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808127
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:6120497
Age: postnatal day 3.5
Specimen Label: 1H
Detected: true
Specimen Num: 8
GXD Expression
Probe: MGI:3055307
Assay Type: RNA in situ
Annotation Date: 2004-11-03
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808022
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:3055933
Age: embryonic day 14.5
Image: E14 WT
Note: Expression is in the cervical loops.
Specimen Label: E14 WT
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:3055307
Assay Type: RNA in situ
Annotation Date: 2004-11-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3808022
Stage: TS22
Assay Id: MGI:3055933
Age: embryonic day 14.5
Image: E14 Runx2-/-
Note: Absence of expression reflects a failure of cervical loop formation.
Specimen Label: E14 Runx2-/-
Detected: false
Specimen Num: 3
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808022
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:6120497
Age: embryonic day 14.5
Specimen Label: 1B
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3808024
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6120497
Age: embryonic day 16.5
Specimen Label: 1C
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3809222
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:6120497
Age: embryonic day 14.5
Specimen Label: 1B
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6119675
Assay Type: Immunohistochemistry
Annotation Date: 2018-03-09
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3809324
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6120497
Age: embryonic day 16.5
Specimen Label: 1C
Detected: true
Specimen Num: 3
Publication
First Author: Prunier C
Year: 2005
Journal: J Biol Chem
Title: Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT).
Volume: 280
Issue: 17
Pages: 17540-8
Publication
First Author: Sterner-Kock A
Year: 2002
Journal: Genes Dev
Title: Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.
Volume: 16
Issue: 17
Pages: 2264-73
Publication  
First Author: Talts JF
Year: 1995
Journal: J Cell Sci
Title: Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma.
Volume: 108 ( Pt 6)
Pages: 2153-62
Publication
First Author: Crawford SE
Year: 1998
Journal: Cell
Title: Thrombospondin-1 is a major activator of TGF-beta1 in vivo.
Volume: 93
Issue: 7
Pages: 1159-70
Publication
First Author: Awwad K
Year: 2015
Journal: Cardiovasc Res
Title: Role of secreted modular calcium-binding protein 1 (SMOC1) in transforming growth factor β signalling and angiogenesis.
Volume: 106
Issue: 2
Pages: 284-94
Publication
First Author: Fang J
Year: 2017
Journal: PLoS One
Title: Conditional removal of the canonical TGF-β1 signaling delays condylar cartilage degeneration induced by a partial discectomy in mice.
Volume: 12
Issue: 5
Pages: e0177826
Publication
First Author: Oliveira VG
Year: 2011
Journal: Eur J Immunol
Title: Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells.
Volume: 41
Issue: 5
Pages: 1249-55
Publication
First Author: Liu S
Year: 2014
Journal: J Bone Miner Res
Title: Role of TGF-β in a mouse model of high turnover renal osteodystrophy.
Volume: 29
Issue: 5
Pages: 1141-57
Publication
First Author: Shull MM
Year: 1992
Journal: Nature
Title: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.
Volume: 359
Issue: 6397
Pages: 693-9
Publication
First Author: Rudner LA
Year: 2003
Journal: J Immunol
Title: Necroinflammatory liver disease in BALB/c background, TGF-beta 1-deficient mice requires CD4+ T cells.
Volume: 170
Issue: 9
Pages: 4785-92
Publication
First Author: Bommireddy R
Year: 2008
Journal: Clin Immunol
Title: TGFbeta1 deficiency does not affect the generation and maintenance of CD4+CD25+FOXP3+ putative Treg cells, but causes their numerical inadequacy and loss of regulatory function.
Volume: 127
Issue: 2
Pages: 206-13
Publication
First Author: Lee HT
Year: 2008
Journal: Am J Physiol Renal Physiol
Title: Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway.
Volume: 295
Issue: 1
Pages: F128-36
Publication
First Author: Saito H
Year: 1999
Journal: Biochem Biophys Res Commun
Title: Induction of the alpha(1)-antichymotrypsin gene in the brain associated with TGF-beta1 deficiency or systemic administration of endotoxin.
Volume: 263
Issue: 2
Pages: 270-5
Publication
First Author: Do JS
Year: 2010
Journal: J Immunol
Title: Cutting edge: spontaneous development of IL-17-producing gamma delta T cells in the thymus occurs via a TGF-beta 1-dependent mechanism.
Volume: 184
Issue: 4
Pages: 1675-9
Publication
First Author: Ingman WV
Year: 2006
Journal: Endocrinology
Title: Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest.
Volume: 147
Issue: 2
Pages: 835-45
Publication
First Author: Fern RJ
Year: 1999
Journal: J Clin Invest
Title: Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice.
Volume: 103
Issue: 1
Pages: 39-46
Publication
First Author: Lanz TV
Year: 2010
Journal: J Clin Invest
Title: Angiotensin II sustains brain inflammation in mice via TGF-beta.
Volume: 120
Issue: 8
Pages: 2782-94
Publication
First Author: Mamura M
Year: 2004
Journal: Blood
Title: CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1.
Volume: 103
Issue: 12
Pages: 4594-601
Publication
First Author: Kramer EL
Year: 2018
Journal: Am J Physiol Lung Cell Mol Physiol
Title: Subacute TGFβ expression drives inflammation, goblet cell hyperplasia, and pulmonary function abnormalities in mice with effects dependent on CFTR function.
Volume: 315
Issue: 3
Pages: L456-L465
Publication
First Author: Yahata T
Year: 2017
Journal: Blood
Title: TGF-β-induced intracellular PAI-1 is responsible for retaining hematopoietic stem cells in the niche.
Volume: 130
Issue: 21
Pages: 2283-2294
Publication
First Author: Farhat YM
Year: 2015
Journal: J Cell Physiol
Title: TGF-β1 Suppresses Plasmin and MMP Activity in Flexor Tendon Cells via PAI-1: Implications for Scarless Flexor Tendon Repair.
Volume: 230
Issue: 2
Pages: 318-26
Publication
First Author: Ghosh AK
Year: 2010
Journal: Circulation
Title: Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.
Volume: 122
Issue: 12
Pages: 1200-9
Publication
First Author: Logan R
Year: 2021
Journal: Sci Rep
Title: TGF-β regulation of the uPA/uPAR axis modulates mesothelial-mesenchymal transition (MesoMT).
Volume: 11
Issue: 1
Pages: 21210
Publication
First Author: Windish HP
Year: 2009
Journal: J Leukoc Biol
Title: Aberrant TGF-beta signaling reduces T regulatory cells in ICAM-1-deficient mice, increasing the inflammatory response to Mycobacterium tuberculosis.
Volume: 86
Issue: 3
Pages: 713-25
Publication
First Author: De Paiva CS
Year: 2011
Journal: PLoS One
Title: Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca.
Volume: 6
Issue: 12
Pages: e29017
Publication
First Author: Laouar Y
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis.
Volume: 105
Issue: 31
Pages: 10865-70
Publication
First Author: Rhodes SD
Year: 2013
Journal: J Bone Miner Res
Title: Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
Volume: 28
Issue: 12
Pages: 2476-89
Publication
First Author: Delisle JS
Year: 2013
Journal: Genes Immun
Title: The TGF-β-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells.
Volume: 14
Issue: 2
Pages: 115-26
Publication
First Author: Roarty K
Year: 2007
Journal: Development
Title: Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth.
Volume: 134
Issue: 21
Pages: 3929-39
Publication
First Author: Alvarez J
Year: 2004
Journal: Dev Dyn
Title: Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Volume: 230
Issue: 4
Pages: 685-99
Publication
First Author: Piccirillo CA
Year: 2002
Journal: J Exp Med
Title: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
Volume: 196
Issue: 2
Pages: 237-46
Publication
First Author: McKarns SC
Year: 2005
Journal: J Immunol
Title: Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3.
Volume: 174
Issue: 4
Pages: 2071-83
Publication
First Author: Sato M
Year: 2003
Journal: J Clin Invest
Title: Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
Volume: 112
Issue: 10
Pages: 1486-94
Publication
First Author: Balooch G
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: TGF-beta regulates the mechanical properties and composition of bone matrix.
Volume: 102
Issue: 52
Pages: 18813-8
Publication
First Author: Banh A
Year: 2006
Journal: Invest Ophthalmol Vis Sci
Title: Lens-specific expression of TGF-beta induces anterior subcapsular cataract formation in the absence of Smad3.
Volume: 47
Issue: 8
Pages: 3450-60
Publication
First Author: Zhang Y
Year: 2014
Journal: Mol Ther
Title: miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling.
Volume: 22
Issue: 5
Pages: 974-85
Publication
First Author: Flanders KC
Year: 2003
Journal: Am J Pathol
Title: Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.
Volume: 163
Issue: 6
Pages: 2247-57
Publication
First Author: Lakos G
Year: 2004
Journal: Am J Pathol
Title: Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
Volume: 165
Issue: 1
Pages: 203-17
Publication
First Author: Yadav H
Year: 2011
Journal: Cell Metab
Title: Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.
Volume: 14
Issue: 1
Pages: 67-79
Publication
First Author: Xu YP
Year: 2012
Journal: J Invest Dermatol
Title: TGFβ/Smad3 signal pathway is not required for epidermal Langerhans cell development.
Volume: 132
Issue: 8
Pages: 2106-9
Publication
First Author: Nakabayashi T
Year: 1997
Journal: J Immunol
Title: Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice.
Volume: 158
Issue: 11
Pages: 5527-35
Publication
First Author: Pandey J
Year: 2007
Journal: Carcinogenesis
Title: Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.
Volume: 28
Issue: 12
Pages: 2589-96
Publication
First Author: Kawasaki K
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans.
Volume: 111
Issue: 21
Pages: 7723-8
Publication
First Author: McCartney-Francis NL
Year: 2002
Journal: J Immunol
Title: Dysregulation of IFN-gamma signaling pathways in the absence of TGF-beta 1.
Volume: 169
Issue: 10
Pages: 5941-7
Publication
First Author: Bodegas E
Year: 2004
Journal: Int J Dev Biol
Title: Depressed adrenomedullin in the embryonic transforming growth factor-beta1 null mouse becomes elevated postnatally.
Volume: 48
Issue: 1
Pages: 67-70
Publication
First Author: Pérez-Rivero G
Year: 2008
Journal: Free Radic Biol Med
Title: Telomerase deficiency promotes oxidative stress by reducing catalase activity.
Volume: 45
Issue: 9
Pages: 1243-51
Publication
First Author: Peters T
Year: 2005
Journal: EMBO J
Title: Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation.
Volume: 24
Issue: 19
Pages: 3400-10
Publication
First Author: Arnold SA
Year: 2012
Journal: PLoS One
Title: Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.
Volume: 7
Issue: 2
Pages: e31384
Publication
First Author: Ma LJ
Year: 2003
Journal: Am J Pathol
Title: Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
Volume: 163
Issue: 4
Pages: 1261-73
Publication
First Author: Vander Lugt B
Year: 2011
Journal: PLoS One
Title: TGF-β suppresses β-catenin-dependent tolerogenic activation program in dendritic cells.
Volume: 6
Issue: 5
Pages: e20099
Publication  
First Author: Robertson JV
Year: 2013
Journal: Mol Vis
Title: Altered expression of transforming growth factor beta 1 and matrix metalloproteinase-9 results in elevated intraocular pressure in mice.
Volume: 19
Pages: 684-95
Publication
First Author: Dong J
Year: 2017
Journal: Part Fibre Toxicol
Title: Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation.
Volume: 14
Issue: 1
Pages: 18
Publication
First Author: Xu Q
Year: 2013
Journal: J Neurosci
Title: Peripheral TGF-β1 signaling is a critical event in bone cancer-induced hyperalgesia in rodents.
Volume: 33
Issue: 49
Pages: 19099-111
Publication  
First Author: Bjarnadóttir K
Year: 2016
Journal: Sci Rep
Title: B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.
Volume: 6
Pages: 34594
Publication
First Author: Li Y
Year: 2023
Journal: Bone Res
Title: Neutralization of excessive levels of active TGF-β1 reduces MSC recruitment and differentiation to mitigate peritendinous adhesion.
Volume: 11
Issue: 1
Pages: 24
Publication
First Author: Sorkin M
Year: 2020
Journal: Nat Commun
Title: Regulation of heterotopic ossification by monocytes in a mouse model of aberrant wound healing.
Volume: 11
Issue: 1
Pages: 722
Publication
First Author: Kelly FM
Year: 2009
Journal: Am J Physiol Renal Physiol
Title: TGF-beta upregulation drives tertiary lymphoid organ formation and kidney dysfunction in calcineurin A-alpha heterozygous mice.
Volume: 296
Issue: 3
Pages: F512-20